Objective To determine the outcomes in children with MIS-C receiving different
immunomodulatory treatment. Methods In this multicentric, retrospective cohort study, data …

Multisystem inflammatory syndrome in children (MIS-C) is a serious condition characterized
by excessive inflammation that can arise as a complication of SARS-CoV-2 infection in …

Objective To study the clinical profile and outcome of children with MIS-C treated with
methylprednisolone pulse therapy and/or intravenous immunoglobulin (IVIG). Method This …

Background. There is limited information available regarding the management of
multisystem inflammatory syndrome in children (MIS‐C) associated with SARS‐CoV‐2. We …

To the Editor: Multisystem inflammatory syndrome in children (MIS-C) have been reported
from various parts of the globe including India sharing clinical features with Kawasaki …

Background Multisystem inflammatory syndrome in children (MIS-C) is a post-infectious
sequelae of acute COVID-19 infection affecting children. This study was done over a period …

Objectives We describe the presentation, treatment and outcome of children with
multisystem inflammatory syndrome with COVID-19 (MIS-C) in Mumbai metropolitan area in …

With the increased spread of severe acute respiratory syndrome coronavirus 2 infection,
more patients with multisystem inflammatory syndrome in children (MIS-C) are being …

Background The objective of the study is to describe the presentation, treatment and
outcomes of children with multisystem inflammatory syndrome with COVID-19 (MIS-C) in a …

Background With the rise of the COVID-19 pandemic, a new severe life-threatening
inflammatory syndrome has been reported in some pediatric populations. Global attention …